Prostate cancer prevention trial and european randomized study of screening for prostate cancer risk calculators: A performance comparison in a contemporary screened cohort

European Urology

Volumn 58, Issue 4, 2010, Pages 551-558

  Cavadas, Vítor ^a   Osório, Luís ^a   Sabell, Francisco ^a   Teves, Frederico ^a   Branco, Frederico ^a   Silva Ramos, Miguel ^a  

^a Centro Hospitalar Universitario do Porto   (Portugal)

Author keywords

Diagnosis; Prostate biopsy; Prostate cancer; Risk calculators

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BIOPSY; CALIBRATION; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER TEST; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; TRANSRECTAL ULTRASONOGRAPHY; UNIVARIATE ANALYSIS;

AGED; COHORT STUDIES; EUROPE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 78650255605     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.06.023     Document Type: Article

References (13)

1. F. Schröder, and M.W. Kattan The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review Eur Urol 54 2008 274 290
2. Risk of biopsy-detectable prostate cancer. University of Texas Health Science Center San Antonio Web site. http://deb.uthsca.edu/URORiskCalc/Pages/ uroriskcalc.jsp. Accessed November 2009.
3. Background information. SWOP Prostate Cancer Research Foundation Web site. http://www.prostatecancer-riskcalculator.com/via.html. Accessed November 2009.
4. I.M. Thompson, D.P. Ankerst, and C. Chi Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529 534 (Pubitemid 43898816)
5. M.J. Roobol, E.W. Steyerberg, and R. Kranse A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer Eur Urol 57 2010 79 85
6. D.J. Parekh, D.P. Ankerst, and B.A. Higgins External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population Urology 68 2006 1152 1155
7. D.J. Hernandez, M. Han, and E.B. Humphreys Predicting the outcome of prostate biopsy: comparison of a novel regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone BJU Int 103 2009 609 614
8. S.J. Eyre, D.P. Ankerst, and J.T. Wei Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection J Urol 182 2009 2653 2658
9. C.T. Nguyen, C. Yu, A. Moussa, M.W. Kattan, and J.S. Jones Performance of Prostate Cancer Prevention Trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy J Urol 183 2010 529 533
10. ®. ERSPC Rotterdam, Helsinki and Tampere Eur Urol Suppl 8 2009 192
11. R.C.N. Van den Bergh, M.J. Roobol, T. Wolters, P.J. van Leeuwen, and F.H. Schröder The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison BJU Int 102 2008 1068 1073
12. A.J. Vickers, and E.B. Elkin Decision curve analysis: a novel method for evaluating prediction models Med Decis Making 26 2006 565 574
13. E.W. Steyerberg, and E.J. Vickers Decision curve analysis: a discussion Med Decis Making 28 2008 146 149